Immunyx Pharma

Immunyx is developing the next generation of immuno-modulatory drugs focusing on toxic neutrophils in chronic disease.

  • Stage Product In Development
  • Industry Biotechnology
  • Location New York City, NY, USA
  • Currency USD
  • Founded April 2021
  • Employees 5
  • Incorporation Type C-corp
  • Website immunyx.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free